× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
Treament Trials   auto
deathsclinical improvementdeath or ventilation
0---
0---
2 -524 [-869; -179] /10000
35/541 vs. 61/521
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-
1 1250 [-3573; 6073] /10000
1/4 vs. 1/8
--
1 -126 [-272; 20] /10000
513/4148 vs. 546/4008
--150 [-313; 14] /10000
631/4014 vs. 670/3891
0---
0---
0---
0 / 1 ---
1 / 2 189 [-355; 732] /10000
9/161 vs. 3/81
242 [-570; 1053] /10000
147/161 vs. 72/81
-179 [-1038; 681] /10000
17/161 vs. 10/81
0---
0---
0---

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments
  718
studies with results
  1743
studies screend
  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons